Literature DB >> 19956968

Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Justus G Garweg1, Yvonne de Kozak, Brigitte Goldenberg, Matthias Boehnke.   

Abstract

BACKGROUND: Patients with ocular toxoplasmosis (OT) develop autoreactivity to several retinal antigens, including retinal S-antigen. By establishing an experimental rabbit model of systemic and of primary and secondary ocular toxoplasmosis, we wished to investigate the onset and development of humoral response to retinal S-antigen.
METHODS: Of twelve infection-naïve rabbits, six were left untreated, and the other six were infected subcutaneously with 5,000 tachyzoites of the highly virulent, non-cyst-forming BK-strain of Toxoplasma gondii. Three months later, the left eye of each animal was infected transvitreally with 5,000 tachyzoites of the same strain. The right eye of each rabbit served as an uninfected control. Blood and aqueous humor were collected prior to infection, and up to 90 days thereafter. Using the ELISA technique, all samples were analyzed in parallel for total IgG, and antibodies against toxoplasmic, bovine retinal S-antigen and peptide 35 from human S-antigen.
RESULTS: In infection-naïve rabbits Toxoplasma-specific antibodies were detected 10 to 15 days after systemic and ocular infection. Serum antibodies against retinal S-antigen and peptide 35 were not detected in response to systemic Toxoplasma infection. After ocular challenge, aqueous-humour levels of antibodies against retinal S-antigen and peptide 35 in the infected eye began to rise 10 to 15 days later in infection-naïve, but not in infection-immunized animals. During the early post-infection period, the concentrations of anti-retinal antibodies in the infected eye correlated with the severity of inflammatory tissue destruction, but returned to baseline later even though the inflammatory response persisted. In the uninfected partner eye, concentrations of anti-retinal and toxoplasmic antibodies did not correlate with each other.
CONCLUSION: Our data afford no evidence of similarities between toxoplasmic and retinal antigens, nor of infection-induced humoral autoimmunity. They indicate rather that retinal autoantigens are liberated in the context of inflammatory tissue destruction due to ocular toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956968     DOI: 10.1007/s00417-009-1242-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  49 in total

1.  Human antiretinal antibodies in toxoplasma retinochoroiditis.

Authors:  R M Whittle; G R Wallace; R A Whiston; D C Dumonde; M R Stanford
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens.

Authors:  R B Nussenblatt; K K Mittal; S Fuhrman; S D Sharma; A G Palestine
Journal:  Am J Ophthalmol       Date:  1989-06-15       Impact factor: 5.258

3.  Human S-antigen determinant recognition in uveitis.

Authors:  M D de Smet; G Bitar; S Mainigi; R B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-12       Impact factor: 4.799

Review 4.  Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity.

Authors:  Dales S Gregerson
Journal:  Int Rev Immunol       Date:  2002 Mar-Jun       Impact factor: 5.311

Review 5.  Regulation of ocular inflammation--what experimental and human studies have taught us.

Authors:  M D de Smet; C C Chan
Journal:  Prog Retin Eye Res       Date:  2001-11       Impact factor: 21.198

Review 6.  When T-helper cells don't help: immunopathology during concomitant infection.

Authors:  Andrea L Graham
Journal:  Q Rev Biol       Date:  2002-12       Impact factor: 4.875

7.  Immunological characterization of an immunomodulatory epitope in S-antigen/arrestin with a sequence motif common to tumor necrosis factor alpha.

Authors:  R H Stiemer; H Gausepohl; M Mirshahi; Y de Kozak; M Kraft; J P Faure; R W Frank
Journal:  Immunol Lett       Date:  1992-05       Impact factor: 3.685

8.  Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis?

Authors:  E La Hey; L Broersma; R van der Gaag; G S Baarsma; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

9.  Anti-retinal S-antigen antibodies in human sera: a comparison of reactivity in ELISA with human or bovine S-antigen.

Authors:  G Doekes; L Luyendijk; M J Gerritsen; A Kijlstra
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

10.  Cellular immune responsiveness of uveitis patients to retinal S-antigen.

Authors:  R B Nussenblatt; I Gery; E J Ballintine; W B Wacker
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

View more
  3 in total

1.  Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.

Authors:  Abeer A El-Henawy; Eman Abdel Razek Hafez; Nairmen Nabih; Naglaa M Shalaby; Mervat Mashaly
Journal:  Rheumatol Int       Date:  2017-03-20       Impact factor: 2.631

2.  Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis.

Authors:  Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

3.  Correlation of Immunological Markers with Disease and Clinical Outcome Measures in Patients with Autoimmune Retinopathy.

Authors:  Lynn K Stanwyck; Weilin Chan; Arjun Sood; Gayatri Susarla; John Romano; Maria Pefkianaki; Kanishka Thiran Jayasundera; John R Heckenlively; Steven K Lundy; Lucia Sobrin
Journal:  Transl Vis Sci Technol       Date:  2020-06-16       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.